GROWTH / DIRECT CATALOG PRICING
Tesamorelin
Tesamorelin is a stabilized 44-amino-acid analogue of human growth-hormone-releasing hormone.
- Format
- Lyophilized research vial
- Listed formats
- 2
- Available now
- 2
- Catalog class
- Growth
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
Tesamorelin is a stabilized 44-amino-acid analogue of human growth-hormone-releasing hormone.
The growth classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Growth
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- 2 formats currently orderable
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
Tesamorelin is a stabilized 44-amino-acid analogue of human growth-hormone-releasing hormone.
- Research covered
- Randomized placebo-controlled trials studied tesamorelin in people with HIV and abdominal fat accumulation, including a 404-participant 12-month study and pooled phase 3 analyses. These studies measured body-composition and laboratory endpoints in that defined population.
- Important limit
- Clinical evidence is population-, formulation-, and indication-specific and does not authenticate this catalog's 5 mg or 10 mg research vials. It should not be generalized to other populations or used as purchasing or administration guidance.
FACTUAL FAQ
Tesamorelin catalog questions
What formats are currently listed?
5 mg, 10 mg. Current price and stock state appear above.
What did researchers study?
Randomized placebo-controlled trials studied tesamorelin in people with HIV and abdominal fat accumulation, including a 404-participant 12-month study and pooled phase 3 analyses. These studies measured body-composition and laboratory endpoints in that defined population.
What is the most important evidence limit?
Clinical evidence is population-, formulation-, and indication-specific and does not authenticate this catalog's 5 mg or 10 mg research vials. It should not be generalized to other populations or used as purchasing or administration guidance.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →
